Developer docs
API playgroundTry for free, no card

Search company profiles

Centinel Spine

Full company profile

uuid0000k8z

Namestring
Centinel Spine
Legal namestring
Centinel Spine, LLC
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Centinel Spine, LLC is a privately held U.S. medical device company founded in 2008 and headquartered in West Chester, Pennsylvania, exclusively focused on motion-preservation total disc replacement (TDR) for cervical and lumbar spinal disease. The company sells a portfolio of FDA-approved implants under the prodisc brand: four cervical devices (prodisc C, prodisc C Vivo, prodisc C SK, prodisc C Nova) and one lumbar device (prodisc L), all powered by the proprietary prodisc CORE Technology — a ball-and-socket articulating design with a fixed center of rotation that provides stability while resisting shear forces. The Match-the-Disc Platform enables intraoperative implant selection across anatomic variants, a capability unique in the U.S. cervical TDR market. Centinel Spine traces its clinical heritage to 1990, with 300,000+ devices implanted globally and 590+ peer-reviewed publications supporting the technology.

The business model is hardware sales of implants and surgical instruments to hospitals and spine surgeons via an enterprise field sales motion with an internal Account Management team. Surgeon education (cadaver labs, surgical demonstrations at conferences such as NASS, medical education website) and patient awareness programs (rediscovermylife.org, PGA Tour athlete endorsements) drive top-of-funnel demand, while a Patient Access Program supports reimbursement navigation. Approximately 95% of the U.S. population has insurance coverage for one-level lumbar TDR, with two-level LTDR still expanding carrier adoption. Pricing is not publicly disclosed.

In Q3 2025, prodisc TDR revenue exceeded $30 million (+42% YoY) with U.S. revenue at nearly $27 million (+46% YoY), and the company reported positive EBITDA at its February 2025 $60 million debt refinancing with SLR Capital Partners. The 2023 divestiture of the spine fusion business to Silony Spine sharpened the company's focus on TDR, and the October 2025 FDA approval of two-level indications for prodisc C Vivo and prodisc C SK reinforced its position as the only company in the world with two different devices approved for both one- and two-level cervical use. The company maintains an international office in Switzerland (Centinel Spine Schweiz GmbH) for European market operations.

Short descriptiontext

Centinel Spine is a privately held U.S. medical device company that designs, manufactures, and sells total disc replacement implants (prodisc brand) for cervical and lumbar spinal disease, selling through enterprise field sales to spine surgeons, hospitals, and surgical centers in the U.S. and Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWest Chester, United States
HQ citystring
West Chester
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spinal implants, total disc replacement, cervical disc arthroplasty, lumbar disc arthroplasty, motion preservation devices
Industry1 code
PRIMARYHLAHAEAC
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Spinal Implants
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Centinel Spine generates revenue through the sale of total disc replacement implants and surgical instruments to hospitals and surgeons. Products include prodisc C (cervical) and prodisc L (lumbar) total disc replacement systems along with associated instrumentation.

centinelspine.com
2Product Revenue
TypeHardware Sales
Description

The company reported over $30 million in prodisc TDR revenue in Q3 2025, representing 42% growth year-over-year. Record U.S. revenue of nearly $27 million achieved in Q3 2025.

prnewswire.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1prodisc
Description

Total disc replacement technology platform including cervical (prodisc C, prodisc C Vivo, prodisc C SK, prodisc C Nova) and lumbar (prodisc L) devices.

centinelspine.com
+3 more records
Core offering1 text field

Centinel Spine designs, manufactures, and sells cervical and lumbar total disc replacement (TDR) implants under the prodisc brand. Its product set includes prodisc C, prodisc C Vivo, prodisc C SK, prodisc C Nova (cervical) and prodisc L (lumbar), all powered by the proprietary prodisc CORE Technology and offered through the Match-the-Disc Platform. The company sells these implants directly to hospitals and spine surgeons, supported by surgeon training, cadaver labs, and reimbursement assistance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 87.1% Composite Clinical Success rate at 24 months for two-level cervical TDR (vs 83.7% for Mobi-C, 81.4% for Prestige LP, 69.7% for Simplify)
+3 more records
Product overview1 text field

Centinel Spine is a medical device company exclusively focused on total disc replacement (TDR) solutions, offering a comprehensive portfolio under the prodisc brand. The portfolio includes five cervical devices (prodisc C, prodisc C Vivo, prodisc C SK, prodisc C Nova) and one lumbar device (prodisc L), all powered by the prodisc CORE Technology. The Match-the-Disc Platform enables surgeons to select the optimal implant design intraoperatively. The company holds over 35 years of clinical experience with more than 300,000 device implantations globally.

Product and service5 records
1prodisc C
CategoryCervical total disc replacement implant
Description

Anterior cervical total disc replacement system; the most studied TDR system in the world with over 300,000 implantations. FDA-approved for 1-level use; uses cobalt chrome alloy endplates with UHMWPE inlay.

2prodisc C Vivo
CategoryCervical total disc replacement implant
Description

Keel-less cervical total disc replacement with a domed superior endplate and lateral spikes for fixation equivalent to keeled devices; enables one-step insertion and is FDA-approved for both 1- and 2-level use.

3prodisc C SK
CategoryCervical total disc replacement implant
Description

Cervical total disc replacement with flat endplates and a smaller keel than prodisc C; FDA-approved for both 1- and 2-level use; features streamlined keel preparation and trapezoidal footprint.

4prodisc C Nova
CategoryCervical total disc replacement implant
Description

Cervical total disc replacement with flat endplates and unique tri-keel fixation; FDA-approved for 1-level use; low-profile keels and anatomical trapezoidal footprint reduce intraoperative remodeling.

5prodisc L
CategoryLumbar total disc replacement implant
Description

Anterior lumbar total disc replacement system; the only TDR system in the U.S. approved for two-level use in the lumbar spine. Features cobalt chrome alloy endplates, UHMWPE inlay, central keel, lateral spikes, and Anatomic Endplate options for customized fit across L3-S1.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2019-01-01
Description

Limited partnership with Tiger Woods following his spinal fusion surgery using Centinel Spine's product in April 2017. His subsequent Masters win in April 2019 demonstrated the company's technology enabling return to elite performance.

2Brian Gay
Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2018-03-20
Description

Five-time PGA Tour Winner Brian Gay partnered with Centinel Spine since 2018 following his successful prodisc C surgery in 2014. Partnership aims to educate high-performing individuals that spinal injury does not require living with pain.

centinelspine.com
3Rory Sabbatini
Strategic tierFlagshipTypeGTM or Marketing PartnerAnnounced on2018-03-20
Description

Six-time PGA Tour Winner Rory Sabbatini entered limited partnership with Centinel Spine in 2018 following his prodisc C surgery in 2016. Partnership showcases successful return to professional golf and active lifestyle.

centinelspine.com
4Cervical Spine Research Society (CSRS)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Development partnership with CSRS for prodisc C Vivo cervical total disc replacement system. Dr. Philip Louie performed cadaveric surgical technique demonstration developed in conjunction with CSRS.

centinelspine.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Dr. Robert Masson, a prodisc C recipient, races with Performance Tech Motorsports team and has won multiple IMSA Prototype racing events post-surgery.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers3 records
TypeBroad incumbent
TypeBroad incumbent
Description

Medtronic offers the Prestige LP cervical disc replacement, one of the three competing cervical TDR products benchmarked against prodisc. As the largest medical device company globally, Medtronic competes through its enormous sales force, hospital relationships, and diversified spine portfolio, but cervical TDR is a small slice of its broader business.

TypeDirect peer
Description

Direct competitor through the Mobi-C cervical total disc replacement system. ZimVie Spine is one of the most established pure-play spine medical device companies and Centinel's primary head-to-head rival in cervical TDR, with comparative clinical data benchmarks cited in Centinel's IDE studies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Centinel Spine

Spinal Implantscentinelspine.com

Centinel Spine is a privately held U.S. medical device company that designs, manufactures, and sells total disc replacement implants (prodisc brand) for cervical and lumbar spinal disease, selling through enterprise field sales to spine surgeons, hospitals, and surgical centers in the U.S. and Europe.

What Centinel Spine does

Centinel Spine, LLC is a privately held U.S. medical device company founded in 2008 and headquartered in West Chester, Pennsylvania, exclusively focused on motion-preservation total disc replacement (TDR) for cervical and lumbar spinal disease. The company sells a portfolio of FDA-approved implants under the prodisc brand: four cervical devices (prodisc C, prodisc C Vivo, prodisc C SK, prodisc C Nova) and one lumbar device (prodisc L), all powered by the proprietary prodisc CORE Technology — a ball-and-socket articulating design with a fixed center of rotation that provides stability while resisting shear forces. The Match-the-Disc Platform enables intraoperative implant selection across anatomic variants, a capability unique in the U.S. cervical TDR market. Centinel Spine traces its clinical heritage to 1990, with 300,000+ devices implanted globally and 590+ peer-reviewed publications supporting the technology.

The business model is hardware sales of implants and surgical instruments to hospitals and spine surgeons via an enterprise field sales motion with an internal Account Management team. Surgeon education (cadaver labs, surgical demonstrations at conferences such as NASS, medical education website) and patient awareness programs (rediscovermylife.org, PGA Tour athlete endorsements) drive top-of-funnel demand, while a Patient Access Program supports reimbursement navigation. Approximately 95% of the U.S. population has insurance coverage for one-level lumbar TDR, with two-level LTDR still expanding carrier adoption. Pricing is not publicly disclosed.

In Q3 2025, prodisc TDR revenue exceeded $30 million (+42% YoY) with U.S. revenue at nearly $27 million (+46% YoY), and the company reported positive EBITDA at its February 2025 $60 million debt refinancing with SLR Capital Partners. The 2023 divestiture of the spine fusion business to Silony Spine sharpened the company's focus on TDR, and the October 2025 FDA approval of two-level indications for prodisc C Vivo and prodisc C SK reinforced its position as the only company in the world with two different devices approved for both one- and two-level cervical use. The company maintains an international office in Switzerland (Centinel Spine Schweiz GmbH) for European market operations.

Centinel Spine firmographics

Firmographics
Name
Centinel Spine
Legal name
Centinel Spine, LLC
Website
https://centinelspine.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
101–250 employees
Short description
Centinel Spine is a privately held U.S. medical device company that designs, manufactures, and sells total disc replacement implants (prodisc brand) for cervical and lumbar spinal disease, selling through enterprise field sales to spine surgeons, hospitals, and surgical centers in the U.S. and Europe.
Ownership category
akta.pro rank

Centinel Spine industry classification

Industry
Product category
Spinal Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAEAC
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Spinal implants
  • Total disc replacement
  • Cervical disc arthroplasty
  • Lumbar disc arthroplasty
  • Motion preservation devices

Where Centinel Spine is headquartered

Location

Headquarters

HQ city
West Chester
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Centinel Spine business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Centinel Spine generates revenue through the sale of total disc replacement implants and surgical instruments to hospitals and surgeons. Products include prodisc C (cervical) and prodisc L (lumbar) total disc replacement systems along with associated instrumentation.
  2. Product Revenue: The company reported over $30 million in prodisc TDR revenue in Q3 2025, representing 42% growth year-over-year. Record U.S. revenue of nearly $27 million achieved in Q3 2025.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Centinel Spine product offering

Product offering

Core offering

Centinel Spine designs, manufactures, and sells cervical and lumbar total disc replacement (TDR) implants under the prodisc brand. Its product set includes prodisc C, prodisc C Vivo, prodisc C SK, prodisc C Nova (cervical) and prodisc L (lumbar), all powered by the proprietary prodisc CORE Technology and offered through the Match-the-Disc Platform. The company sells these implants directly to hospitals and spine surgeons, supported by surgeon training, cadaver labs, and reimbursement assistance.

Product overview

Centinel Spine is a medical device company exclusively focused on total disc replacement (TDR) solutions, offering a comprehensive portfolio under the prodisc brand. The portfolio includes five cervical devices (prodisc C, prodisc C Vivo, prodisc C SK, prodisc C Nova) and one lumbar device (prodisc L), all powered by the prodisc CORE Technology. The Match-the-Disc Platform enables surgeons to select the optimal implant design intraoperatively. The company holds over 35 years of clinical experience with more than 300,000 device implantations globally.

Differentiator

Problem solved

Functional benefit

Brands

  • prodisc: Total disc replacement technology platform including cervical (prodisc C, prodisc C Vivo, prodisc C SK, prodisc C Nova) and lumbar (prodisc L) devices.
  • reDiscover
  • Match-the-Disc
  • prodisc CORE

Products and services

  • prodisc C Anterior cervical total disc replacement system; the most studied TDR system in the world with over 300,000 implantations. FDA-approved for 1-level use; uses cobalt chrome alloy endplates with UHMWPE inlay.
  • prodisc C Vivo Keel-less cervical total disc replacement with a domed superior endplate and lateral spikes for fixation equivalent to keeled devices; enables one-step insertion and is FDA-approved for both 1- and 2-level use.
  • prodisc C SK Cervical total disc replacement with flat endplates and a smaller keel than prodisc C; FDA-approved for both 1- and 2-level use; features streamlined keel preparation and trapezoidal footprint.
  • prodisc C Nova Cervical total disc replacement with flat endplates and unique tri-keel fixation; FDA-approved for 1-level use; low-profile keels and anatomical trapezoidal footprint reduce intraoperative remodeling.
  • prodisc L Anterior lumbar total disc replacement system; the only TDR system in the U.S. approved for two-level use in the lumbar spine. Features cobalt chrome alloy endplates, UHMWPE inlay, central keel, lateral spikes, and Anatomic Endplate options for customized fit across L3-S1.

Quantifiable outcome

  • 87.1% Composite Clinical Success rate at 24 months for two-level cervical TDR (vs 83.7% for Mobi-C, 81.4% for Prestige LP, 69.7% for Simplify)
  • +3 more outcomes

Companies that use Centinel Spine

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles1 record

Centinel Spine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Centinel Spine partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered flagship, core and minor.

  • Tiger WoodsflagshipGTM or Marketing Partner · 1 January 2019Limited partnership with Tiger Woods following his spinal fusion surgery using Centinel Spine's product in April 2017. His subsequent Masters win in April 2019 demonstrated the company's technology enabling return to elite performance.
  • Brian GayflagshipGTM or Marketing Partner · 20 March 2018Five-time PGA Tour Winner Brian Gay partnered with Centinel Spine since 2018 following his successful prodisc C surgery in 2014. Partnership aims to educate high-performing individuals that spinal injury does not require living with pain.
  • Rory SabbatiniflagshipGTM or Marketing Partner · 20 March 2018Six-time PGA Tour Winner Rory Sabbatini entered limited partnership with Centinel Spine in 2018 following his prodisc C surgery in 2016. Partnership showcases successful return to professional golf and active lifestyle.
  • Cervical Spine Research Society (CSRS)coreStrategic or Co-development PartnerDevelopment partnership with CSRS for prodisc C Vivo cervical total disc replacement system. Dr. Philip Louie performed cadaveric surgical technique demonstration developed in conjunction with CSRS.
  • Performance Tech MotorsportsminorGTM or Marketing PartnerDr. Robert Masson, a prodisc C recipient, races with Performance Tech Motorsports team and has won multiple IMSA Prototype racing events post-surgery.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Centinel Spine competitors and assessment

Company assessment

Broad incumbents

  • NuVasive (now Globus Medical):
  • Medtronic: Medtronic offers the Prestige LP cervical disc replacement, one of the three competing cervical TDR products benchmarked against prodisc. As the largest medical device company globally, Medtronic competes through its enormous sales force, hospital relationships, and diversified spine portfolio, but cervical TDR is a small slice of its broader business.

Direct peers

  • ZimVie (formerly Zimmer Biomet Spine): Direct competitor through the Mobi-C cervical total disc replacement system. ZimVie Spine is one of the most established pure-play spine medical device companies and Centinel's primary head-to-head rival in cervical TDR, with comparative clinical data benchmarks cited in Centinel's IDE studies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Centinel Spine social profiles

Digital presence

Centinel Spine compliance and trust

Trust signal

Compliance2 records

Centinel Spine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Centinel Spine leadership team

Management profile

Number of profiles

Profiles6 records

Centinel Spine subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Centinel Spine funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Centinel Spine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centinel Spine

What does Centinel Spine do?

Centinel Spine designs, manufactures, and sells cervical and lumbar total disc replacement (TDR) implants under the prodisc brand. Its product set includes prodisc C, prodisc C Vivo, prodisc C SK, prodisc C Nova (cervical) and prodisc L (lumbar), all powered by the proprietary prodisc CORE Technology and offered through the Match-the-Disc Platform. The company sells these implants directly to hospitals and spine surgeons, supported by surgeon training, cadaver labs, and reimbursement assistance.

Is Centinel Spine a public or private company?

Centinel Spine is a private company. It is classified as unknown and is currently operating.

When was Centinel Spine founded?

Centinel Spine was founded in 2008. It employs 101 to 250 people.

Where is Centinel Spine based?

Centinel Spine is headquartered in West Chester, United States, in the North America region.

How does Centinel Spine make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are product Revenue.

Who are Centinel Spine's main competitors?

Broad incumbents on record are NuVasive (now Globus Medical) and Medtronic. ZimVie (formerly Zimmer Biomet Spine) is listed as a direct peer.

Does Centinel Spine have an API?

No public API is recorded for Centinel Spine.

What industry is Centinel Spine in?

Centinel Spine's product category is Spinal Implants. Its primary akta.pro industry code is HLAHAEAC, Spine Implants & Motion Preservation (Fusion/Disc/Interspinous). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Renaissance CapitalUS IPO Week Ahead: November’s IPO market set for a quiet startThe U.S. IPO week ahead features only one SPAC, Football Manager SPAC, tentatively scheduled to raise $100 million. Two medical companies, vVardis and Centinel Spine, may proceed despite an AI sell-off. Anthropic is expected to dominate the calendar.Medical Device NetworkCentinel Spine gets FDA nod for two-level use of prodisc C NovaCentinel Spine received FDA approval for two-level use of its prodisc C Nova cervical total disc replacement system. The clearance allows implantation across two cervical levels, and the company now offers three cervical devices cleared for single- and two-level applications. The implant is available in the US on a limited-release basis.Investing.comMedical device maker Centinel Spine discloses revenue rise in US IPO filingCentinel Spine disclosed a revenue rise in its IPO filing, reporting net income of $10.2 million on $85.2 million revenue for the six months ended June 30, up from a $503,000 loss on $60.1 million revenue a year earlier. The company plans to use proceeds to repay debt and invest in sales infrastructure and clinical trials.ReutersMedical device maker Centinel Spine discloses revenue rise in US IPO filingCentinel Spine disclosed a revenue rise in its IPO filing, posting net income of $10.2 million on $85.2 million revenue for the six months ended June 30, up from a $503,000 loss on $60.1 million revenue a year earlier. The company plans to use proceeds to repay debt and invest in sales infrastructure and clinical trials.MarketScreenerMedical device maker Centinel Spine discloses revenue rise in US IPO filingCentinel Spine disclosed a revenue rise in its IPO filing, posting net income of $10.2 million on $85.2 million revenue for the six months ended June 30, up from a $503,000 loss on $60.1 million revenue a year earlier. The company plans to use proceeds to repay debt and invest in sales infrastructure and clinical trials.Investing.comCentinel Spine Holdco files for IPOCentinel Spine Holdco filed for a NYSE IPO on Wednesday. The company, a commercial-stage medical technology firm, focuses on Total Disc Replacement for cervical and lumbar spine surgery. Morgan Stanley, Goldman Sachs, Piper Sandler, Canaccord Genuity, and BTIG will serve as underwriters.openPR.comMarket Driver Insights: The Impact of Recent Advances on the Lumbar Disc Replacement Devices MarketThe Business Research Company published a market report projecting the lumbar disc replacement devices market will reach $2.39 billion by 2030, growing at a 12.9% CAGR, driven by demand for motion-preserving surgical options and personalized implant designs. In January 2023, the American Medical Association introduced a new CPT code for second-level lumbar total disc replacement, which US-based Centinel Spine LLC subsequently utilized to expand access to two-level TDR surgeries. The report identifies key market trends including minimally invasive procedures, biocompatible material innovations, and custom implant designs.PR NewswireCentinel Spine® Commemorates 35 Years of prodisc® Clinical Leadership in an Era of Continuing InnovationCentinel Spine announced the commemoration of 35 years of clinical leadership for its prodisc total disc replacement platform, highlighting over 540 published papers and sustained long-term function. The company has recently expanded its U.S. FDA-approved indications to include two-level cervical and lumbar treatments, alongside launching new anatomical implant options and instrument systems. This announcement underscores Centinel Spine's position as a leading global medical device company focused exclusively on spinal disease treatment.PR NewswireCoverage Expansion Continues for One- and Two-Level Lumbar Total Disc Replacement as One of the Leading Commercial Payers in Arizona Establishes Positive Coverage Criteria for Centinel Spine's prodiscA major commercial payer in Arizona has expanded coverage criteria for one- and two-level lumbar total disc replacement, specifically covering Centinel Spine's prodisc L device—the only FDA-approved two-level lumbar TDR option—for over one million people in the state. Commercial coverage for one-level TDR has grown to nearly 95% and two-level to over 40% of commercially covered lives in the U.S. This reflects a national trend toward broader access to lumbar TDR based on long-term clinical evidence and surgeon experience.PR NewswireCentinel Spine® Grows prodisc® Total Disc Replacement 42% Worldwide in Third Quarter 2025 with Record EBITDA ResultsCentinel Spine announced record revenue of over $32 million in Q3 2025, a 42% increase year-over-year, driven by growth in its prodisc total disc replacement technology. The company received FDA approval for two-level indications for its cervical TDR devices and expanded its international regulatory certifications.